XTRA:HPHABiotechs
Heidelberg Pharma (XTRA:HPHA) Stock Faces Q2 Profit That Leaves Loss Narratives Intact
Heidelberg Pharma (XTRA:HPHA) has released its Q2 2026 numbers, reporting total revenue of €6.2 million, basic EPS of €0.0187 and net income of €0.9 million, with the trailing twelve months still showing a loss of €33.1 million and EPS of €0.7080. Over recent quarters the company has seen revenue move from €0.1 million in Q2 2025 to €6.2 million in Q2 2026, while quarterly EPS shifted from a loss of €0.1400 to a modest profit of €0.0187. For investors, the combination of higher revenue and a...